Psychiatry & AI

With depression affecting roughly 280 million people globally, the demand for mental health support far outstrips the availability of human therapists. To address this gap, the FDA's Digital Health Advisory Committee recently evaluated the use of generative AI therapy chatbots. These conversational tools use natural language processing to simulate therapeutic dialogues, mimicking techniques like cognitive behavioral therapy. The committee reviewed existing studies to determine if these automated systems can safely and effectively support patients, marking a major step toward regulating and integrating conversational artificial intelligence into mainstream mental healthcare.